Issue

Vol. 36 No. 6 (2024): Vol 36 Issue 6, 2024

Copyright (c) 2024 Ekta Khare, Zeeshan Fatima, O.P. Tiwari, Jeevan Patra, Unnati Kushavah

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Novel Carbazoles as AChE Inhibitors: Synthesis, Molecular Docking and Dynamic Simulation Studies

https://doi.org/10.14233/ajchem.2024.31559
Ekta Khare
Amity Institute of Pharmacy Lucknow, Amity University Uttar Pradesh, Sector 125, Noida-201313, India; Department of Pharmaceutical Chemistry, GCRG College of Pharmacy, Lucknow-271835, India
https://orcid.org/0000-0002-6541-6002
Zeeshan Fatima
Amity Institute of Pharmacy Lucknow, Amity University Uttar Pradesh, Sector 125, Noida-201313, India
https://orcid.org/0000-0001-5841-9312
O.P. Tiwari
Department of Pharmaceutical Chemistry, Vindhya Gurukul College of Pharmacy (Affiliated to Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh), Lucknow-226021, India
Jeevan Patra
Amity Institute of Pharmacy Lucknow, Amity University Uttar Pradesh, Sector 125, Noida-201313, India
https://orcid.org/0000-0002-2709-4268
Unnati Kushavah
Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Sitapur Road, Lucknow-226031, India

Corresponding Author(s) : Zeeshan Fatima

zfatima@amity.edu

Asian Journal of Chemistry, Vol. 36 No. 6 (2024): Vol 36 Issue 6, 2024

Abstract

Extensive exploration of N-substituted carbazole derivatives is underway as these compounds possess the therapeutic potential to address the neurological problems. The main aim of this study is to synthesize a series of N-substituted carbazole derivatives and investigate it’s in vitro and in silico ability to act as AChE inhibitors. The two-step synthesis was carried out that resulted in the development of novel carbazoles and then these were subsequently subjected to in vitro evaluation for acetylcholinesterase (AChE) inhibitory activity. Further to comprehend the binding interactions and establish a plausible binding mechanism, the molecular docking, molecular dynamics and computational ADME predictions were employed. Based on its IC50 value of 14.14 µM, -7.327 Kcal/mol binding energy and occupancy of the egg yolk region, which suggests the potential for brain entry, compound 4c was determined to be an active one among the synthesized compounds. Thus, compound 4c has the potential to be an AChE inhibitor and effective in treating Alzheimer’s disease.

Keywords

Carbazoles Acetylcholinesterase inhibitors Anti-Alzheimer Synthesis Molecular docking Dynamics
Khare, E., Fatima, Z., Tiwari, O., Patra, J., & Kushavah, U. (2024). Novel Carbazoles as AChE Inhibitors: Synthesis, Molecular Docking and Dynamic Simulation Studies. Asian Journal of Chemistry, 36(6), 1417–1422. https://doi.org/10.14233/ajchem.2024.31559
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. P. Scheltens, B. De Strooper, M Kivipelto, H. Holstege, G. Chételat, C.E. Teunissen, J. Cummings, W.M. van der Flier, Lancet, 397, 1577 (2021); https://doi.org/10.1016/s0140-6736(20)32205-4
  2. R.K. Chaudhary, U.V. Mateti, P. Khanal, K.B. Rawal, P. Jain, V.S. Patil, A.K. Shrivastava and B M Patil, Alzheimer's Disease: Epidemiology, Neuropathology and Neurochemistry, In: Computational and Experimental Studies in Alzheimer’s Disease: CRC Press, pp. 1-14 (2024).
  3. Alzheimer’s Disease Facts and Figures, Alzheimers Dement., 20, 3708 (2024); https://doi.org/10.1002/alz.13809
  4. S. Samanta, M. Ramesh and T. Govindaraju, in eds.: T. Govindaraju, Alzheimer’s Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities, The Royal Society of Chemistry, Chap. 1, p. 34 (2022).
  5. Z.R. Chen, J.B. Huang, S.L. Yang and F.F. Hong, Molecules, 27, 1816 (2022); https://doi.org/10.3390/molecules27061816
  6. K. Sharma, Mol. Med. Rep., 20, 1479 (2019); https://doi.org/10.3892/mmr.2019.10374
  7. M.B. Colovic, D.Z. Krstic, T.D. Lazarevic-Pašti, A.M. Bondžic and V. M. Vasic, Curr Neuropharmacol., 11, 315 (2013); https://doi.org/10.2174/1570159x11311030006
  8. M. Saxena and R. Dubey, Curr. Top. Med. Chem., 19, 264 (2019); https://doi.org/10.2174/1568026619666190128125912
  9. D.B. Barbosa, M.R. do Bomfim, T.A. de Oliveira, A.M. da Silva, A.G. Taranto, J.N. Cruz, P.B. de Carvalho, J.M. Campos, C.B.R. Santos and F.H.A. Leite, Pharmaceuticals, 16, 1657 (2023); https://doi.org/10.3390/ph16121657
  10. N. Kumar, P. Gupta and S. Bansal, Lett. Drug Design Discov., 19, 1049 (2022); https://doi.org/10.2174/1570180819666220314144219
  11. B.C. Nandy, A. Gupta, A. Mittal and V. Vyas, J. Biomed. Pharm. Res., 3, 42 (2014).
  12. L.S. Tsutsumi, D. Gündisch and D. Sun, Curr. Top. Med. Chem., 16, 1290 (2016); https://doi.org/10.2174/1568026615666150915112647
  13. A Caruso, A. Barbarossa, A. Carocci, G. Salzano, M.S. Sinicropi and C. Saturnino, Appl. Sci., 11, 6192 (2021); https://doi.org/10.3390/app11136192
  14. A. Caruso, J. Ceramella, D. Iacopetta, C. Saturnino, M.V. Mauro, R. Bruno, S. Aquaro and M.S. Sinicropi, Molecules, 24, 1912 (2019); https://doi.org/10.3390/molecules2410191
  15. S.O. Bachurin, E.V. Bovina and A.A. Ustyugov, Med. Res. Rev., 37, 1186 (2017); https://doi.org/10.1002/med.21434
  16. C. Chen, X. Wang, D. Xu, H. Zhang, H.-N. Chan, Z. Zhan, S. Jia, Q. Song, G. Song, H.-W. Li and M.S. Wong, J. Mater. Chem. B, 11, 4865 (2023); https://doi.org/10.1039/D3TB00082F
  17. D.V. Patel, N.R. Patel, A.M. Kanhed, D.M. Teli, K.B. Patel, P.D. Joshi, S.P. Patel, P.M. Gandhi, B.N. Chaudhary, N.K. Prajapati, K.V. Patel and M.R. Yadav, Bioorg. Chem., 101, 103 (2020); https://doi.org/10.1016/j.bioorg.2020.103977
  18. Y.P. Singh, N. Kumar, B. S. Chauhan, and P. Garg, Drug Dev. Res., 84, 1624 (2023); https://doi.org/10.1002/ddr.22113
  19. A. Rampa, S. Montanari, L. Pruccoli, M. Bartolini, F. Falchi, A. Feoli, A. Cavalli, F. Belluti, S. Gobbi, A. Tarozzi and A. Bisi, Future Med. Chem., 9, 749 (2017); https://doi.org/10.4155/fmc-2017-0029
  20. U. Košak, N. Strašek, D. Knez, M. Jukic, S. Žakelj , A. Zahirovic, A. Pišlar, X. Brazzolotto, F. Nachon, J. Kos and S. Gobe, Eur. J. Med. Chem., 197, 112282 (2020); https://doi.org/10.1016/j.ejmech.2020.112282
  21. H. Zhang, Y. Wang, Y. Wang, X. Li, S. Wang and Z. Wang, Eur. J. Med. Chem., 240, 114606 (2022); https://doi.org/10.1016/j.ejmech.2022.114606
  22. M. Alipour M. Khoobi, A. Moradi, H. Nadri, F.H. Moghadam, S. Emami, Z. Hasanpour, A. Foroumadi and A. Shafiee. Eur. J. Med. Chem., 82, 536 (2014); https://doi.org/10.1016/j.ejmech.2014.05.056
  23. N. Mishra and D. Sasmal, Bioorg. Med. Chem. Lett., 23, 702 (2013); https://doi.org/10.1016/j.bmcl.2012.11.100
  24. H. Akrami, B.F. Mirjalili, M. Khoobi, A. Moradi, A. Sakhteman, H. Nadri, S. Emami, A. Foroumadi and A. Shafiee, Eur. J. Med. Chem., 84, 375 (2014); https://doi.org/10.1016/j.ejmech.2014.01.017
  25. E. Nepovimova, J. Korabecny, R. Dolezal, K. Babkova, A. Ondrejicek, D. Jun, V. Sepsova, A. Horova, M. Hrabinova, O. Soukup, N. Bukum, P. Jost, L. Muckova, J. Kassa, D. Malinak, M. Andrs and K. Kuca, J. Med. Chem., 58, 8985 (2015); https://doi.org/10.1021/acs.jmedchem.5b01325
  26. S.P. Mantoani, T.P.C. Chierrito, A.F.L. Vilela, C.L. Cardoso, A. Martínez and I. Carvalho, Molecules, 21, 193 (2016); https://doi.org/10.3390/molecules21020193
  27. S.L. Motebennur, B.P. Nandeshwarappa and M.S. Katagi, Drugs Drug Cand., 2, 571 (2022); https://doi.org/10.3390/ddc2030030
  28. Z.-M. Wang, P. Cai, Q.-H. Liu, D.-Q. Xu, X.-L. Yang, J.-J. Wu, L.-Y. Kong and X.-B. Wang, Eur. J. Med. Chem., 123, 282 (2016); https://doi.org/10.1016/j.ejmech.2016.07.052
  29. W. Stadlbauer, V.H. Dang and N. Guttenberger, J. Heterocycl. Chem., 52, 114 (2014); https://doi.org/10.1002/jhet.1994
  30. P. Bar-On, C.B. Millard, M. Harel, H. Dvir, A. Enz, J.L. Sussman and I. Silman, Biochemistry, 41, 3555 (2002); https://doi.org/10.1021/bi020016x
  31. A. Daina, O. Michielin and V. Zoete, Sci. Rep., 7, 42717 (2017); https://doi.org/10.1038/srep42717
  32. A. Daina and V. Zoete, Chem. Med. Chem., 11, 1117 (2016); https://doi.org/10.1002/cmdc.201600182
  33. M. Pohanka, M. Hrabinova, K. Kuca and J.P. Simonato, Int. J. Mol. Sci., 12, 2631 (2011); https://doi.org/10.4149/BLL_2013_153
  34. M. Shahrivar-Gargari, M. Hamzeh-Mivehroud, S. Hemmati, J.S. Mojarrad, T.T. Kuçukkilinç, B. Ayazgok and S. Dastmalchi, Arch. Pharm., 354, 2000453 (2021); https://doi.org/10.1002/ardp.202000453
Read More
Author biographies is not available.
Statistic
Read Counter : 0 Download : 0